Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.53 - $0.93 $2,724 - $4,780
-5,140 Reduced 3.74%
132,382 $76,000
Q3 2023

Nov 15, 2023

BUY
$1.12 - $1.88 $337 - $565
301 Added 0.22%
137,522 $155,000
Q2 2023

Aug 11, 2023

BUY
$1.31 - $2.04 $26,705 - $41,587
20,386 Added 17.45%
137,221 $219,000
Q4 2022

Aug 11, 2023

BUY
$2.02 - $3.25 $17,935 - $28,856
8,879 Added 8.22%
116,835 $280,000
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.25 $17,935 - $28,856
8,879 Added 8.22%
116,835 $280,000
Q3 2022

Aug 11, 2023

SELL
$1.96 - $3.14 $6,687 - $10,713
-3,412 Reduced 3.06%
107,956 $221,000
Q3 2022

Nov 03, 2022

SELL
$1.96 - $3.14 $6,687 - $10,713
-3,412 Reduced 3.06%
107,956 $221,000
Q2 2022

Aug 11, 2023

BUY
$1.3 - $2.64 $29,166 - $59,231
22,436 Added 25.23%
111,368 $216,000
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.64 $29,166 - $59,231
22,436 Added 25.23%
111,368 $216,000
Q1 2022

Aug 11, 2023

SELL
$2.35 - $3.47 $65,572 - $96,823
-27,903 Reduced 23.88%
88,932 $218,000
Q1 2022

May 20, 2022

SELL
$2.35 - $3.47 $49,723 - $73,421
-21,159 Reduced 19.22%
88,932 $219,000
Q4 2021

Feb 16, 2022

BUY
$2.92 - $5.74 $13,662 - $26,857
4,679 Added 4.44%
110,091 $354,000
Q3 2021

Nov 12, 2021

SELL
$4.98 - $6.63 $29,725 - $39,574
-5,969 Reduced 5.36%
105,412 $553,000
Q2 2021

Aug 12, 2021

BUY
$2.56 - $5.49 $42,716 - $91,606
16,686 Added 17.62%
111,381 $611,000
Q1 2021

May 03, 2021

SELL
$2.69 - $5.25 $8,301 - $16,201
-3,086 Reduced 3.16%
94,695 $258,000
Q4 2020

Feb 12, 2021

BUY
$3.17 - $4.49 $36,626 - $51,877
11,554 Added 13.4%
97,781 $311,000
Q3 2020

Nov 09, 2020

BUY
$2.98 - $5.2 $6,946 - $12,121
2,331 Added 2.78%
86,227 $345,000
Q2 2020

Aug 10, 2020

BUY
$2.29 - $4.24 $29,987 - $55,522
13,095 Added 18.5%
83,896 $333,000
Q1 2020

May 15, 2020

BUY
$1.92 - $4.39 $9,154 - $20,931
4,768 Added 7.22%
70,801 $173,000
Q4 2019

Feb 14, 2020

SELL
$2.41 - $4.4 $11,179 - $20,411
-4,639 Reduced 6.56%
66,033 $269,000
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $15,870 - $19,069
6,273 Added 9.74%
70,672 $212,000
Q1 2019

May 13, 2019

BUY
$2.51 - $3.73 $12,524 - $18,612
4,990 Added 8.4%
64,399 $191,000
Q4 2018

Feb 14, 2019

SELL
$1.59 - $2.66 $10,899 - $18,234
-6,855 Reduced 10.34%
59,409 $142,000
Q3 2018

Nov 14, 2018

SELL
$1.59 - $2.42 $3,033 - $4,617
-1,908 Reduced 2.8%
66,264 $142,000
Q2 2018

Aug 14, 2018

BUY
$2.26 - $4.65 $18,952 - $38,994
8,386 Added 14.03%
68,172 $155,000
Q1 2018

May 15, 2018

SELL
$3.51 - $6.04 $10,389 - $17,878
-2,960 Reduced 4.72%
59,786 $282,000
Q4 2017

Feb 08, 2018

BUY
$3.26 - $4.78 $2,888 - $4,235
886 Added 1.43%
62,746 $205,000
Q3 2017

Nov 14, 2017

BUY
$3.48 - $4.44 $215,272 - $274,658
61,860
61,860 $273,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.